These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17609444)

  • 21. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
    J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma.
    Sakr AA; Saleh AA; Moeaty AA; Moeaty AA
    Eur J Radiol; 2005 Jun; 54(3):418-25. PubMed ID: 15899345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis.
    Chu HH; Kim JH; Yoon HK; Ko HK; Gwon DI; Kim PN; Sung KB; Ko GY; Kim SY; Park SH
    J Vasc Interv Radiol; 2019 Oct; 30(10):1533-1543. PubMed ID: 31471190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.
    Kitamoto M; Imagawa M; Yamada H; Watanabe C; Sumioka M; Satoh O; Shimamoto M; Kodama M; Kimura S; Kishimoto K; Okamoto Y; Fukuda Y; Dohi K
    AJR Am J Roentgenol; 2003 Oct; 181(4):997-1003. PubMed ID: 14500217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
    Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
    J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Chang NK; Shin SS; Kim JW; Kim HJ; Jeong YY; Heo SH; Kim JK; Kang HK
    Korean J Radiol; 2012; 13 Suppl 1(Suppl 1):S104-11. PubMed ID: 22563280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation.
    Yamakado K; Nakatsuka A; Takaki H; Sakurai H; Isaji S; Yamamoto N; Shiraki K; Takeda K
    AJR Am J Roentgenol; 2010 Feb; 194(2):530-5. PubMed ID: 20093620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients.
    Yamakado K; Anai H; Takaki H; Sakaguchi H; Tanaka T; Kichikawa K; Takeda K
    AJR Am J Roentgenol; 2009 Jun; 192(6):W300-5. PubMed ID: 19457793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma.
    Yuan W; Yang MJ; Xu J; Yan ZP; Liu R; Qu XD; Wang JH; Qian S
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818788529. PubMed ID: 30045673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
    Choi JW; Kim HC; Lee JH; Yu SJ; Cho EJ; Kim MU; Hur S; Lee M; Jae HJ; Chung JW
    J Vasc Interv Radiol; 2017 Jun; 28(6):795-803.e1. PubMed ID: 28302348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
    Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
    J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transarterial Chemoembolization Combined with Simultaneous Thermal Ablation for Solitary Hepatocellular Carcinomas in Regions with a High Risk of Recurrence.
    Özen Ö; Boyvat F; Zeydanlı T; Kesim Ç; Karakaya E; Haberal M
    Exp Clin Transplant; 2023 Jun; 21(6):512-519. PubMed ID: 37455470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.